戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              PHA-L labeling showed that labeled corticothalamic termi
2                                              PHA-L was also placed into the dorsal raphe nuclei or nu
3                                              PHA-L was first injected into either the lateral or vent
4                                              PHA-L-immunoreactive (IR) fibers showing preterminal and
5                                              PHA-L-labeled fibers were observed in the ipsilateral po
6                                              PHA-L-labeled trigemino- and spinothalamic (TSTT) termin
7 etention of high levels of p27(Kip1) in IL-2/PHA-L-treated T cells bound to CDK2.
8 unostained with an antibody directed against PHA-L.
9  marker Phaseolus vulgaris leuco-agglutinin (PHA-L) was injected into individual PAG columns or adjoi
10  marker Phaseolus vulgaris leuco-agglutinin (PHA-L) with a particular focus on determining whether th
11             Approximately 19% of the BDA and PHA-L axon terminals examined originating from the commi
12 ers were injected into the dentate gyrus and PHA-L and BDA were injected into the entorhinal cortex t
13 the anterograde tracers BDA, neurobiotin and PHA-L in the host.
14                              In PVH, NPY and PHA-L double-labeled fibers were found mainly in the par
15 al procedure for co-visualization of PRV and PHA-L was used to identify the sympathetic premotor regi
16 d based on random overlap of TrkB puncta and PHA-L--labeled afferents, 3 of 5 anti-TrkB antibodies te
17 ainst VGluT2, tyrosine hydroxylase (TH), and PHA-L.
18 ns of ChAT-immunoreactive neurons apposed by PHA-L-labeled input from medial VTA (mainly in vertical
19 s form synapses identical to those formed by PHA-L-immunolabeled axons with parvalbumin neurons; and
20 esizing neurons appeared to be innervated by PHA-L-containing axons.
21 he AGm, a double-labeling strategy combining PHA-L injections in the SNR and pressure injections of t
22 lyclonal antibodies were used to demonstrate PHA-L, tyrosine hydroxylase, dopamine beta-hydroxylase,
23  examined under a light microscope to detect PHA-L-labeled fibers.
24 ntire DMN or the mid-dorsal part of the DMN, PHA-L-containing axon varicosities were juxtaposed to ap
25 ng of the signal sequence resulted in PHA-E, PHA-L and GNA with heterogenous N-termini, with the majo
26  the tracer, simultaneous immunolabeling for PHA-L and proTRH peptides was performed and mapped in di
27 ined with Cuprolinic blue, and processed for PHA-L using the avidin biotin complex with diaminobenzid
28 roscopy determined the presence of VGluT2 in PHA-L- or WGA-positive terminals.
29                                    Injecting PHA-L into the visual, but not into the auditory AI, rev
30 ed stability of lectin phytohemagglutinin L (PHA-L) compared to the wild type (wt).
31 labeled tissue, we found that double-labeled PHA-L (+)/VGluT2 (+) axon terminals formed synaptic cont
32 by interleukin-2 (IL-2) and leucoagglutinin (PHA-L), whereas the expression of cyclin D2, CDK6, and C
33 ted with Phaseolus vulgaris leucoagglutinin (PHA-L) and labeled dextrans.
34 l tracer Phaseolus vulgaris leucoagglutinin (PHA-L) and performed double-label immunofluorescence wit
35 e tracer Phaseolus vulgaris leucoagglutinin (PHA-L) and the retrograde tracer FluoroGold in specific
36 beled by Phaseolus vulgaris leucoagglutinin (PHA-L) injected into the same MPO stimulation site.
37 beled by Phaseolus vulgaris leucoagglutinin (PHA-L) injections, whereas tyrosine hydroxylase (TH) was
38 ction of Phaseolus vulgaris leucoagglutinin (PHA-L) or an adeno-associated virus encoding wheat germ
39 e tracer Phaseolus vulgaris leucoagglutinin (PHA-L) or the retrograde tracer Texas Red-conjugated dex
40 e tracer Phaseolus vulgaris leucoagglutinin (PHA-L) was injected into one inferior colliculus of 10 a
41 t lectin Phaseolus vulgaris leucoagglutinin (PHA-L) was used to determine whether both of the lateral
42  tracer, Phaseolus vulgaris leucoagglutinin (PHA-L), was iontophresed into the ARH of female rats and
43 as using Phaseolus vulgaris leucoagglutinin (PHA-L).
44  tracers Phaseolus vulgaris-leucoagglutinin (PHA-L) and biotinylated dextran (BD) were injected into
45 rograde [Phasoleus vulgaris-leucoagglutinin (PHA-L) and biotinylated dextran amines (BDA)] tracers we
46  tracers Phaseolus vulgaris-leucoagglutinin (PHA-L) and biotinylated dextranamine (BD), direct spinal
47 (BDA) or Phaseolus vulgaris-leucoagglutinin (PHA-L) from the NTS with gold-silver labeling for tyrosi
48 tions of Phaseolus vulgaris-leucoagglutinin (PHA-L) in the SN, the labeled nigrotegmental fibers were
49 ning for Phaseolus vulgaris-leucoagglutinin (PHA-L) injected into the median raphe (MR) and parvalbum
50 e tracer Phaseolus vulgaris-leucoagglutinin (PHA-L) into discrete parts of the ventral tegmental area
51 e tracer Phaseolus vulgaris-leucoagglutinin (PHA-L) into lamina A of the lateral geniculate nucleus (
52 l tracer Phaseolus vulgaris-leucoagglutinin (PHA-L) into restricted regions of the PAG.
53 e tracer Phaseolus vulgaris-leucoagglutinin (PHA-L) into the pars reticulata of the substantia nigra
54 acing of Phaseolus vulgaris-leucoagglutinin (PHA-L) it was determined if parvalbumin-immunoreactive n
55          Phaseolus vulgaris-leucoagglutinin (PHA-L) was injected in discrete regions of the PAG, and
56   First, Phaseolus vulgaris-leucoagglutinin (PHA-L) was injected in the ventrolateral PAG in Sprague-
57 e tracer Phaseolus vulgaris-leucoagglutinin (PHA-L) were made in the BLA and detailed light microscop
58 BDA) and Phaseolus vulgaris-leucoagglutinin (PHA-L), into four subdivisions of OFC.
59 bstance, Phaseolus vulgaris-leucoagglutinin (PHA-L).
60 e tracer Phaseolus vulgaris-leucoagglutinin (PHA-L).
61 sport of Phaseolus vulgaris-leucoagglutinin (PHA-L); and gamma-aminobutyric acid (GABA)ergic terminal
62  tracers Phaseolus vulgaris-leucoagglutinin (PHA-L; for outputs) and cholera toxin B subunit (CTB; fo
63 nsport of Phaseolus vulgaris leucoagglutinin(PHA-L) or carbocyanine dyes, we characterize the POm tha
64 e tracer Phaseolus vulgaris leukoagglutinin (PHA-L).
65 tracers Phaseolus vulgaris-leuocoagglutinin (PHA-L) and biotinylated dextran amine (BDA).
66                At the ultrastructural level, PHA-L-labeled terminals were found to establish synaptic
67  pallidum co-localized only with TRD and not PHA-L, whereas pallidal MOR1 immunostaining co-localized
68                  In the median eminence, NPY/PHA-L double-labeled fibers were found both in the inner
69      Confocal analysis demonstrated that NPY/PHA-L double-labeled fibers came in close apposition to
70                         Approximately 95% of PHA-L-labeled terminals from the central lateral, midlin
71 rocessed for immunocytochemical detection of PHA-L and parvalbumin (PV) at light and electron microsc
72 cal observations made of the distribution of PHA-L labelled fibres and boutons in the mPFC.
73                      Brainstem injections of PHA-L retrogradely labeled a few myenteric neurons in th
74                    Stereotaxic injections of PHA-L were targeted to the mid-dorsal and mid-ventral po
75 ctivity was detected in the vast majority of PHA-L- or WGA-positive terminals forming asymmetric syna
76 were observed to be enmeshed in a network of PHA-L-containing fibers.
77 ferent PHA alleles affected the stability of PHA-L lectin.
78              By electron microscopy, BDA- or PHA-L-labeled axon terminals originating from the NTS co
79                            Highly restricted PHA-L injections were made in all four PAG columns throu
80 astructural level, about 40% of the selected PHA-L-labeled presynaptic terminals in the ventral palli
81                                We found that PHA-L- or WGA-positive terminals from tagged VTA cells m
82                                 Finally, the PHA-L that spread to the nucleus of the solitary tract o
83 roscopic analysis confirmed that some of the PHA-L-labeled terminals established synaptic contacts wi
84 s were often found in close proximity to the PHA-L-labeled terminals.
85 ouble-labeled preparations using antisera to PHA-L and preproTRH 178-199, the latter as a marker for
86 tes within SM bundles were immunoreactive to PHA-L, tyrosine hydroxylase, and dopamine beta-hydroxyla
87                    Injections of the tracers PHA-L or BDA into these auditory-responsive posterior th
88 rent fluorophores was performed to visualize PHA-L, NPY and CRH, with the aid of confocal microscopy.
89 globus pallidus, and internal capsule, where PHA-L-labeled terminals abutted cholinergic (choline ace
90 double tracer neuroanatomical study in which PHA-L was first iontophoretically ejected into either th
91      Controls included animals injected with PHA-L after intracranial deafferentations.
92 llidal MOR1 immunostaining co-localized with PHA-L and not TRD.